tailieunhanh - Báo cáo y học: "Exciting news from Clinical Proteomic"

Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Critical Care giúp cho các bạn có thêm kiến thức về ngành y học đề tài: Exciting news from Clinical Proteomics. | Chan Clinical Proteomics 2011 8 3 http content 8 1 3 CLINICAL PROTEOMICS EDITORIAL Open Access Exciting news from Clinical Proteomics Daniel W Chan Correspondence dchan@ Professor of Pathology Oncology Radiology and Urology Director Center for Biomarker Discovery and Translation Johns Hopkins Medical Institutions Baltimore MD USA 2 BioMed Central As the Editor-in-Chief of Clinical Proteomics I have exciting news to share with you. Clinical Proteomics is entering a new and exciting era of open access publishing. The journal has now been transferred to BioMed Central an online only open access publisher which is part of Springer Science and Business Media. Becoming open access and online will result in immediate and free access to all articles and faster review and publication times. High visibility will result from all content being made accessible via web search engines as well as indexing with PubMed and PubMed Central. As you know personalized medicine is expected to revolutionize health care delivery in the next decade. I believe that targeted proteomic diagnostics and therapeutics will be the basis of personalized molecular medicine. Recent advances in proteomic and bioinformatic technologies such as mass spectrometry and protein microarrays have been used successfully to detect disease-associated biomarkers in complex biological specimens such as tissues cell lysates serum plasma and other body fluids. Extensive validation will be needed to translate these biomarkers into targeted clinical use. Clinical Proteomics is in the position to take advantage of these opportunities by providing a scholarly forum for novel scientific research in the field of translational proteomics with special emphasis on the application of proteomic technology to all aspects of clinical investigations including academic clinical laboratory pharmaceutical and diagnostic industries. We have assembled a strong editorial team of leading .